PlainRecalls
FDA Drug Moderate Class II Terminated

Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-25.

Reported: March 14, 2018 Initiated: February 20, 2018 #D-0576-2018

Product Description

Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-25.

Reason for Recall

Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.

Details

Units Affected
a) 137,975 vials; b) 40,143 vials
Distribution
Nationwide in the USA and Puerto Rico.
Location
Mcpherson, KS

Frequently Asked Questions

What product was recalled?
Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-25.. Recalled by Hospira Inc. A Pfizer Company. Units affected: a) 137,975 vials; b) 40,143 vials.
Why was this product recalled?
Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 14, 2018. Severity: Moderate. Recall number: D-0576-2018.